Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE EIF2B1-5 genes encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B) were analyzed in all patients with clinically suspected VWM disease. 31385086 2020
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Vanishing white matter disease (VWM) is an autosomal recessive neurological disorder caused by mutation(s) in any subunit of eukaryotic translation initiation factor 2B (eIF2B), an activator of translation initiation factor eIF2. 31587290 2019
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Vanishing white matter disease (VWM) is an inherited leukoencephalopathy in children attributed to mutations in EIF2B1-5, encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B). 30720246 2019
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Vanishing white matter (VWM) disease (OMIM#306896) is an autosomal recessive neurodegenerative leukodystrophy caused by hypomorphic mutations in any of the five genes encoding the subunits of eukaryotic translation initiation factor 2B (eIF2B). 31134486 2019
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Vanishing white matter (VWM) disease is an autosomal genetic leukodystrophy caused by mutations in subunits of eukaryotic translation initiation factor 2B (eIF2B). 30279648 2018
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease GENOMICS_ENGLAND A Novel Mutation in the EIF2B4 Gene Associated with Leukoencephalopathy with Vanishing White Matter. 30073106 2018
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease BEFREE Further dissection of the signaling network associated with eIF2B function will help generating therapeutic strategies for VWM disease and possibly other neurodegenerative disorders. 28306143 2017
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease BEFREE There is sufficient evidence suggesting role of eukaryotic translation initiation factor 2B (EIF2B) gene family encoding the five subunits of eIF2B complex-α, β, γ, δ and ε respectively, in causing vanishing white matter (VWM) disease of the brain. 28093708 2017
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease MGD Astrocytes are central in the pathomechanisms of vanishing white matter. 26974157 2016
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE The genes encoding all five subunits of eukaryotic translation initiation factor 2B (EIF2B) were analyzed in patients, who were tentatively diagnosed with VWM, by Sanger sequencing. 25843247 2015
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome. 26162493 2015
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE It is already known that alterations in Eukaryotic Translation Initiation Factor 2B (EIF2B) gene encoding the five subunits of eIF2B complex cause Vanishing White Matter (VWM) disease of the brain and emerging evidences have advocated certain resemblances between MS and VWM in terms of clinical and epidemiological characteristics, thus validating the association study between EIF2B and MS. 26671108 2015
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease GENOMICS_ENGLAND A genetic analysis was performed for vanishing white matter (VWM) disease and a homozygote c. 1091G>A mutation was detected at the EIF2B4 gene. 26043506 2015
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease GENOMICS_ENGLAND Vanishing white matter disease in a spanish population. 25089094 2014
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease GENOMICS_ENGLAND A practical approach to diagnosing adult onset leukodystrophies. 24357685 2014
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE The typical MRI pattern with a diffuse CSF-like aspect of the cerebral white matter can lack particularly in the adult forms whereas an increasing number of patients with clinical and MRI criteria for CACH/VWM disease but without eIF2B mutations are found. 20016818 2009
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE A unique EIF2B mutation spectrum in Chinese VWM patients was shown. 19158808 2009
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease BEFREE Mutations in eukaryotic translation initiation factor 2B (eIF2B) cause Childhood Ataxia with CNS Hypomyelination (CACH), also known as Vanishing White Matter disease (VWM). 19023445 2008
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Vanishing white matter disease (VWM; MIM #603896), also known as childhood ataxia with central nervous system hypomyelination (CACH) syndrome, is an autosomal recessive transmitted leukoencephalopathy related to mutations in each of the 5 genes (EIF2B1, EIF2B2, EIF2B3, EIF2B4 and EIF2B5) encoding for the 5 subunits of eukaryotic translation initiation factor 2B (eIF2B), essential for protein synthesis. 16998732 2006
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Leukoencephalopathy with vanishing white matter (VWM), also called childhood ataxia with central nervous system hypomyelination (CACH), is an autosomal recessive disease caused by mutations in any of the five genes encoding subunits of the eukaryotic translation initiation factor eIF2B. 16823698 2006
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 Biomarker disease BEFREE The importance of correct control of eIF2 and eIF2B for normal physiology is underlined by the recent involvement of the five genes that encode the five eIF2B subunits in a severe autosomal recessive neurodegenerative disease, described in young children as CACH (childhood ataxia with central nervous system hypomyelination)/VWM (leukoencephalopathy with vanishing white matter) syndrome. 16246171 2006
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 AlteredExpression disease BEFREE This heightened stress response observed in primary fibroblasts that suffer from minor loss of basal eIF2B activity may be employed as an initial screening tool for CACH/VWM leukodystrophy. 16041584 2005
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease UNIPROT Identification of ten novel mutations in patients with eIF2B-related disorders. 15776425 2005
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE Here we have established cell cultures from the brain of an individual with VWM carrying mutations in subunit 5 of eIF2B (encoded by EIF2B5). 15723074 2005
Childhood Ataxia with Central Nervous System Hypomyelinization
0.900 GeneticVariation disease BEFREE We report in an affected man and his mother an adult-onset form of childhood ataxia with central nervous system hypomyelination/vanishing white matter disease-like disorder with no mutations in the EIF2B genes and normal guanine nucleotide exchange factor eIF2B activity, suggesting a new dominant inheritance of this syndrome that may involve other genes. 16047349 2005